Results 231 to 240 of about 243,764 (341)

Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder [PDF]

, 2018
Arpamas Seetasith, Mallik Greene, Ann Hartry, Chakkarin Burudpakdee   +3 more
openalex   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source

A systematic review using the Theoretical Domains Framework to identify barriers and facilitators to the adoption of prescribing guidelines

International Journal of Pharmacy Practice, EarlyView., 2020
Abstract Objectives Evidence‐based guidelines have the potential to reduce variation and increase prescribing quality. Identifying the key determinants to their uptake, using a theory‐based approach, may assist in the design of successful interventions to increase their adoption into practice.
Paulina Paksaite, Margaret Watson, Joel Crosskey, Eni Sula, Celine West   +4 more
wiley   +1 more source

Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.

Schizophrenia bulletin, 2014
T. Kishimoto, Alfred Robenzadeh, C. Leucht, S. Leucht, Koichiro Watanabe, M. Mimura, M. Borenstein, J. Kane, C. Correll   +8 more
semanticscholar   +1 more source

Prepulse Inhibition Deficits in GAD65 Knockout Mice and the Effect of Antipsychotic Treatment [PDF]

, 2004
Scott A. Heldt, Amanda Green, Kerry J. Ressler   +2 more
openalex   +1 more source

Socio‐economic differences in the effectiveness of pharmacotherapy use in alcohol use disorder: A cohort study of 148 626 individuals in Sweden

Addiction, EarlyView.
Abstract Aim To examine the socioeconomic differences in the effectiveness of alcohol use disorders (AUD) pharmacotherapy and risk of AUD hospitalisation. Design A prospective register‐based cohort study. Setting Sweden. Participants Individuals who were registered as living in Sweden in 2005 (16–64 years) with a first‐time AUD diagnosis and complete ...
Devy L. Elling, Emelie Thern, Lluís Mangot‐Sala, Jari Tiihonen, Anders Hammarberg, Daniel Falkstedt, Heidi Taipale   +6 more
wiley   +1 more source

Do the pharmacokinetics of statins explain psychiatric symptom improvement from adjunctive statin prescribing in severe mental illness? Three target trial emulation studies. [PDF]

BMJ Ment Health
Launders N, Richards-Belle A, Hardoon S, Man K, Wong ICK, Osborn DPJ, Hayes JF.   +6 more
europepmc   +1 more source

Psychopharmacological effects of a new antipsychotic, 1-[1-{3-(4-fluorobenzoyl)propyl}-4-piperidyl]-2,3-dihydrobenz-imidazole-2-thione (DD-3480)

, 1977
Terukiyo Yamasaki, Takeo Sakurai, Hiroshi Kojima, Akira Kasahara   +3 more
openalex   +1 more source

Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review

Addiction, EarlyView.
Abstract Background and aims There has been limited evidence synthesis examining the treatment of buprenorphine precipitated opioid withdrawal (BPOW). We aimed to conduct the first systematic review to assess the clinical utility of any pharmacological intervention in the management of BPOW.
Emmert Roberts, Nicola Kalk, John Strang
wiley   +1 more source

Combining Three Long-acting Injectable Antipsychotics: A Case Series. [PDF]

Clin Psychopharmacol Neurosci
İnci Kenar AN, Balki Tekin S.
europepmc   +1 more source